Skip to main content
Equibles
CNSY logo

CNSY · Cerenome, Inc. · Metrics

Track CNSY — free

Use CNSY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CNSY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.39 -0.10 (-4.02%) At close · Sep 10
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These factors raise substantial doubt about the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 14, 2026
Market Cap
$18.90M
Shares
7.59M

CNSY metrics

63 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.39
Market cap
$18.90M

Price action

20 metrics
Price change (1W)
-15.3%
Price change (30D)
-35.0%
Price change (3M)
-53.8%
Price change (6M)
-67.9%
Price change (YTD)
-80.5%
Price change (1Y)
-79.7%
Trailing year
Price change (5Y)
-99.6%
52-week high
$22.25
52-week low
$2.49
Change from 52-week high
-88.8%
Change from 52-week low
+0.0%
Annualized volatility
116.5%
Annualized volatility (3M)
67.9%
Beta
1.8
RSI (14D)
29.2
Price vs SMA 50
-30.4%
Price vs SMA 200
-64.7%
Avg volume (3M)
133,845
Relative volume
0.6
Average dollar volume
$533,354

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
7.59M

Valuation

12 metrics
P / E (TTM)
0.1
Trailing earnings · reciprocal yield 1,099.2%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
4.5×
reciprocal yield 22.2%
P / book
3.5
reciprocal yield 28.9%
FCF yield
-124.6%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-138.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-05-15

Profitability

9 metrics
Gross margin
—
Operating margin
-628.1%
Trailing 12 months
Net margin
-620.7%
Gross profit (TTM)
$441,000
Operating profit (TTM)
−$26.40M
Net income (TTM)
−$26.09M
Trailing 12 months
Diluted EPS (TTM)
$27.37
FCF margin
-560.3%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.72

Growth

11 metrics
Revenue growth YoY
-70.4%
Year over year
Net income growth YoY
-274.8%
Revenue (TTM)
$4.20M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-17.5%
Year over year · fewer shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-477.5%
Return on assets
-185.9%
Debt / equity
—
Current ratio
1.4
EBITDA (TTM)
−$25.95M
Free cash flow (TTM)
−$23.55M
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$2.37M
Total assets
$14.03M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$22.18M
Capital expenditures (TTM)
$1.37M
R&D (TTM)
$12.51M
SG&A (TTM)
—
Stock compensation (TTM)
$3.09M
R&D / revenue
297.6%
Stock compensation / revenue
73.6%

Ownership (13F)

3 metrics
13F filers
21
13F filer change QoQ
-4
Institutional ownership
8.3%

Short interest

3 metrics
Short interest
8.6%
Latest settlement · 8.1 days to cover
Days to cover
8.1d
Short-squeeze score
62 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1095981 CUSIP 72941H806 13F (30d) 13 filings 13 filers Visit website Investor relations